Spyre Therapeutics Inc (SYRE)

Income Before Tax

-$36.20M

Quarterly · Period ending: · USD

SYRE logo

SYRE Income Before Tax

Latest reported-$36.20M
SYRE Quarterly Pre-Tax Income (-$1.52M → -$36.20M)
High-resolution chart · PNG

SYRE income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
-36,200,000
-69,005,000
-62,530,000
-11,183,000
-36,717,000
-44,788,000
-56,295,000
-69,010,000
-38,837,000
-43,825,000
-63,180,000
-40,104,000
-217,074,000
-18,458,000
-18,784,000
-18,443,000
-22,314,000
-24,436,000
-20,423,000
-20,281,000
-6,738,000
-18,218,000
-22,714,000
-18,033,000
-21,418,000
-18,728,000
-21,495,000
-21,573,000
-18,019,000
-17,167,000
-14,898,000
-11,917,000
-9,414,000
-8,119,000
-6,483,000
-7,874,000
-6,632,000
-6,247,000
-5,483,000
-6,238,000
-5,430,000
-4,547,000
-3,987,000
-3,413,000
-1,427,000
-2,468,000
-3,181,000
-3,250,000
-2,396,000
-1,520,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.